About
59.56USD+2.71 +4.77%
Closed • Updated at 13:36 GMT+00:00Market Cap$2.77B
P/E Ratio29.32
Volume1.00M
Beta0.16
RSI55.92
Gross Margin55.70%
Haemonetics Corporation — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
May 5 2026
Haemonetics to Present at Bank of America 2026 Healthcare Conference
Apr 24 2026
New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
Apr 1 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
Mar 30 2026
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
Translate